Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retina Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04141891
What this trial is testing

Advancing Understanding of Transportation Options

Who this might be right for
Diabetic RetinopathyMacular DegenerationGlaucoma+29 more
University of Colorado, Denver 529
Post-approval studies (Phase 4)UnknownNCT04902859
What this trial is testing

Clonidine as Pain Relief During ROP Eye Examinations

Who this might be right for
Retinopathy of PrematurityPain, ProceduralPremature Infant Disease
Region Örebro County 50
Testing effectiveness (Phase 2)Ended earlyNCT00712491
What this trial is testing

Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascularization
Santen Inc. 20
Large-scale testing (Phase 3)UnknownNCT00517257
What this trial is testing

Atorvastatin for the Treatment of Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionRetinal Vein ThrombosisCentral Retinal Vein Occlusion+2 more
University of Toronto 180
Not applicableNot Yet RecruitingNCT07825792
What this trial is testing

Light Bulb Stimuli to Reduce Chronic Pain

Who this might be right for
FibromyalgiaMusculoskeletal Pain
University of North Carolina, Chapel Hill 40
Large-scale testing (Phase 3)Study completedNCT00021736
What this trial is testing

Phase II/III Study of Anti-VEGF in Neovascular AMD

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Eyetech Pharmaceuticals 540
Early research (Phase 1)WithdrawnNCT00538538
What this trial is testing

Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)

Who this might be right for
Retinal HemorrhageMacular Degeneration
Corewell Health East
Early research (Phase 1)Study completedNCT03748784
What this trial is testing

ADVM-022 Intravitreal Gene Therapy for Wet AMD

Who this might be right for
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT05697809
What this trial is testing

Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Oxular Limited 3
Testing effectiveness (Phase 2)Study completedNCT01445899
What this trial is testing

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Who this might be right for
Choroidal NeovascularizationDiabetic RetinopathyDiabetic Macular Edema
Quark Pharmaceuticals 258
Not applicableWithdrawnNCT00813514
What this trial is testing

Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?

Who this might be right for
Choroidal NeoVascularizationAge-Related Macular Degeneration
Medical University of Vienna
Not applicableStudy completedNCT02625649
What this trial is testing

Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes MellitusObesityDiabetic Retinopathy+1 more
University of Aarhus 148
Early research (Phase 1)Study completedNCT00406471
What this trial is testing

Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion

Who this might be right for
Ischemic Central Retinal Vein Occlusion
Greater Houston Retina Research 20
Testing effectiveness (Phase 2)Study completedNCT02504944
What this trial is testing

Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)

Who this might be right for
Retinopathy of Prematurity
Meyer Children's Hospital IRCCS 98
Large-scale testing (Phase 3)Ended earlyNCT01940887
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 645
Large-scale testing (Phase 3)Study completedNCT00523406
What this trial is testing

Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)

Who this might be right for
Macular Degeneration
Medical University of Vienna 40
Post-approval studies (Phase 4)Study completedNCT04774926
What this trial is testing

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 122
Large-scale testing (Phase 3)Ended earlyNCT00505947
What this trial is testing

Treatment of Refractory Diabetic Macular Edema With Infliximab

Who this might be right for
Diabetic Macular EdemaVisual AcuityDiabetic Retinopathy
University of Athens 12
Not applicableStudy completedNCT02645383
What this trial is testing

PASCAL Laser Platform Produces Less Pain Responses Compared To Conventional Laser System

Who this might be right for
Diabetic Retinopathy
Kocatepe University 30
Not applicableStudy completedNCT01846351
What this trial is testing

Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes

Who this might be right for
Epiretinal MembraneAge Related Macular Degeneration
New England Retina Associates 16
Next Page